You have free access to this content

British Journal of Clinical Pharmacology

Cover image for British Journal of Clinical Pharmacology

April 1979

Volume 7, Issue S2

Pages 161S–265S

  1. JOURNAL ARTICLE

    1. Top of page
    2. JOURNAL ARTICLE
    1. You have free access to this content
    2. You have free access to this content
      Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate). (pages 167S–172S)

      RA Vukovich, JE Foley, B Brown, DA Willard, M Buckley, D O'Kelly, D Fitzgerald, W Tormey and A Darragh

      Version of Record online: 26 JUL 2012 | DOI: 10.1111/j.1365-2125.1979.tb04687.x

    3. You have free access to this content
    4. You have free access to this content
      Diuretics as initial treatment for essential hypertension. (pages 185S–187S)

      FA Jr Finnerty

      Version of Record online: 26 JUL 2012 | DOI: 10.1111/j.1365-2125.1979.tb04689.x

    5. You have free access to this content
      Diuretics, beta-blockers or both as treatment for essential hypertension. (pages 189S–197S)

      KO Stumpe and O Overlack

      Version of Record online: 26 JUL 2012 | DOI: 10.1111/j.1365-2125.1979.tb04690.x

    6. You have free access to this content
      Long-term treatment of essential hypertension using nadolol and hydrochlorothiazide combined. (pages 199S–203S)

      MM El-Mehairy, A Shaker, M Ramadan, S Hamza and SS Tadros

      Version of Record online: 26 JUL 2012 | DOI: 10.1111/j.1365-2125.1979.tb04691.x

    7. You have free access to this content
      Orally active angiotensin-converting enzyme inhibitor (SO 14,225) as a treatment for essential hypertension. (pages 205S–211S)

      HR Brunner, H Gavras, B Waeber, GA Turini, DN McKinstry, RA Vukovich and I Gavras

      Version of Record online: 26 JUL 2012 | DOI: 10.1111/j.1365-2125.1979.tb04692.x

    8. You have free access to this content
      beta-Adrenoceptor-blocking agents and the kidney: effect of nadolol and propranolol on the renal circulation. (pages 219S–225S)

      NK Hollenberg, DF Adams, DN McKinstry, GH Williams, LJ Borucki and JM Sullivan

      Version of Record online: 26 JUL 2012 | DOI: 10.1111/j.1365-2125.1979.tb04693.x

    9. You have free access to this content
      Elimination of nadolol by patients with renal impairment. (pages 227S–231S)

      J Herrera, RA Vukovich and DL Griffith

      Version of Record online: 26 JUL 2012 | DOI: 10.1111/j.1365-2125.1979.tb04694.x

    10. You have free access to this content
    11. You have free access to this content
      Influence of various antihypertensive agents on lifespan of renal hypertensive rats. (pages 243S–248S)

      ZP Horovitz, MJ Antonaccio, B Rubin and RE Panasevich

      Version of Record online: 26 JUL 2012 | DOI: 10.1111/j.1365-2125.1979.tb04696.x

    12. You have free access to this content
      Relationship between hypertension and angina pectoris. (pages 249S–253S)

      PJ Richardson and LS Hill

      Version of Record online: 26 JUL 2012 | DOI: 10.1111/j.1365-2125.1979.tb04697.x

    13. You have free access to this content
      Regression of left ventricular hypertrophy during treatment with antihypertensive agents. (pages 255S–260S)

      LS Hill, M Monaghan and PJ Richardson

      Version of Record online: 26 JUL 2012 | DOI: 10.1111/j.1365-2125.1979.tb04698.x

    14. You have free access to this content
      Effect of treatment of hypertension in the primary preventive trial, Goteborg, Sweden. (pages 261S–265S)

      L Wilhelmsen, G Berglund, R Sannerstedt, L Hansson, O Andersson, R Sievertsson and J Wikstrand

      Version of Record online: 26 JUL 2012 | DOI: 10.1111/j.1365-2125.1979.tb04699.x

SEARCH

SEARCH BY CITATION